Our western blot and immunofluorescence analyses further disclosed that inhibiting SNHG25 resulted in decreased Vimentin expression and increased E-Cadherin expression in CRC cells (Figure 3C, 3D). This evidence concerns the gene SNHG25 and colorectal carcinoma.